Metabolomics

Dataset Information

0

Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia (Metabolomic analysis on extracellular vesicles)


ABSTRACT:

Acute myeloid leukemia (AML) is an aggressive disease with a high relapse rate. In this study, we map the metabolic profile of CD34+(CD38low/-) AML cells and the extracellular vesicle signatures in circulation from AML patients at diagnosis. CD34+ AML cells display high antioxidant glutathione levels and enhanced mitochondrial functionality, both associated with poor clinical outcomes. Although CD34+ AML cells are highly dependent on glucose oxidation and glycolysis for energy, those from intermediate- and adverse-risk patients reveal increased mitochondrial dependence. Extracellular vesicles from AML are mainly enriched in stem cell markers and express antioxidant GPX3, with their profiles showing potential prognostic value. Extracellular vesicles enhance mitochondrial functionality and dependence on CD34+ AML cells via the glutathione/GPX4 axis. Notably, only extracellular vesicles from adverse-risk patients enhance leukemia cell engraftment in vivo. Here, we show a potential noninvasive approach based on liquid ‘cell-extracellular vesicle’ biopsy toward a redefined metabolic stratification in AML.


Metabolomic analysis on extracellular vesicles is reported in the current study MTBLS11746.

Lipidomic analysis on extracellular vesicles is reported in MTBLS11523.

INSTRUMENT(S): Gas Chromatography MS - positive

PROVIDER: MTBLS11746 | MetaboLights | 2024-12-04

REPOSITORIES: MetaboLights

Dataset's files

Source:
Action DRS
AcqData-CumulativeAuditTrail.xml Xml
Contents.xml Xml
Devices.xml Xml
MSTS.xml Xml
qqqacqmethod.xml Xml
Items per page:
1 - 5 of 882

Similar Datasets

2024-12-04 | MTBLS11523 | MetaboLights
2014-01-11 | E-GEOD-53974 | biostudies-arrayexpress
2016-03-01 | E-ERAD-439 | biostudies-arrayexpress
| 2332322 | ecrin-mdr-crc
2025-07-30 | GSE270080 | GEO
2025-07-30 | GSE270079 | GEO
2025-07-30 | GSE270078 | GEO
2025-07-30 | GSE270077 | GEO
2023-04-18 | GSE227967 | GEO
2023-08-09 | GSE209589 | GEO